Mammalian Phenotype Ontology Annotations

Mammalian Phenotype Ontology Annotations
Query Results - Summary

419 genotypes with 480 annotations displayed of selected term and subterms
Searched Term: abnormal seizure response to inducing agent
Allelic Composition (Genetic Background)	Annotated Term	Reference
\Adamts4^tm1Dgen/\Adamts4^tm1Dgen (involves: 129P2/OlaHsd * C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:101679
\Adgrv1^frings/\Adgrv1^frings (RB/1)	audiogenic seizures	J:25341
\Adgrv1^frings/\Adgrv1^frings (BUB/BnJ)	audiogenic seizures	J:97534
\Adgrv1^tm1Msat/\Adgrv1^tm1Msat (involves: 129P2/OlaHsd * C57BL/6J)	audiogenic seizures	J:95518
\Adgrv1^tm1Msat/\Adgrv1^tm1Msat (B6.129P2-Adgrv1^tm1Msat)	audiogenic seizures	J:95518
\Adgrv1^tm1Pwh/\Adgrv1^tm1Pwh (involves: 129S1/Sv * C57BL/6J)	audiogenic seizures	J:90899
\Adk^tm2Bois/\Adk^tm2Bois \Adora1^tm1Bbf/\Adora1^tm1Bbf \Tg(Nes-cre)1Kln/0 (involves: 129P2/OlaHsd * C57BL/6 * SJL)	environmentally induced seizures	J:237189
\Adk^tm2Bois/\Adk^tm2Bois \Adora2a^tm1Jfc/\Adora2a^tm1Jfc \Tg(Nes-cre)1Kln/0 (involves: 129S4/SvJae * C57BL/6 * SJL)	decreased susceptibility to induction of seizure by inducing agent	J:237189
\Adk^tm2Bois/\Adk^tm2Bois \Tg(Nes-cre)1Kln/0 (involves: C57BL/6 * SJL)	environmentally induced seizures	J:237189
	increased susceptibility to pharmacologically induced seizures	J:237189
\Agpat1^tm1Garg/\Agpat1^tm1Garg (involves: 129S6/SvEvTac * C57BL/6)	audiogenic seizures	J:250301
\Aifm1^Hq/Y (B6CBACa A^w-J/A-Aifm1^Hq/J)	abnormal seizure response to pharmacological agent	J:98103
\Aifm1^Hq/\Aifm1^Hq (B6CBACa A^w-J/A-Aifm1^Hq/J)	abnormal seizure response to pharmacological agent	J:98103
\Akap5^tm1.1Jsco/\Akap5^tm1.1Jsco (involves: 129S * C57BL/6 * FVB/N)	decreased susceptibility to pharmacologically induced seizures	J:138972
\Akt3^Nmf350/\Akt3⁺ (C57BL/6J-Akt3^Nmf350)	abnormal seizure response to electrical stimulation	J:169028
	increased susceptibility to pharmacologically induced seizures	J:169028
	maximal tonic hindlimb extension seizures	J:169028
\Akt3^Nmf350/\Akt3^Nmf350 (C57BL/6J-Akt3^Nmf350)	abnormal seizure response to electrical stimulation	J:169028
	increased susceptibility to pharmacologically induced seizures	J:169028
	maximal tonic hindlimb extension seizures	J:169028
\Akt3^tm1Mbb/\Akt3^tm1Mbb (involves: C57BL/6J)	abnormal seizure response to electrical stimulation	J:169028
\Akt3^tm1Mbb/\Akt3^tm1Mbb (involves: C57BL/6J)	maximal tonic hindlimb extension seizures	J:169028
\Alg13^em1Bayu/Y (involves: C57BL/6J)	environmentally induced seizures	J:275180
\Alg13^em1Bayu/Y (involves: C57BL/6J)	increased susceptibility to pharmacologically induced seizures	J:275180
\Amph^tm1Pdc/\Amph^tm1Pdc (involves: 129/Sv * C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:75306
\Ano3^tm1.1Lyj/\Ano3^tm1.1Lyj \Ptgds^{tm1.1(cre)Gvn}/\Ptgds⁺ (involves: 129X1/SvJ * C57BL/6 * FVB/N)	environmentally induced seizures	J:310618
\Ano3^tm1.1Lyj/\Ano3^tm1.1Lyj \Tg(Nes-cre)1Kln/0 (involves: 129X1/SvJ * C57BL/6)	environmentally induced seizures	J:310618
\Ap3m2^tm1Ohno/\Ap3m2^tm1Ohno (involves: 129P2/OlaHsd * C57BL/6)	abnormal kindling response	J:93312
	increased susceptibility to pharmacologically induced seizures	J:93312
\Apoe^tm1Unc/\Apoe^tm1Unc (B6.129P2-Apoe^tm1Unc)	abnormal kindling response	J:118390
\Arhgap32^tm1Taki/\Arhgap32^tm1Taki (B6N.Cg-Arhgap32^tm1Taki)	increased susceptibility to pharmacologically induced seizures	J:236753
\Arx^tm3Kki/Y (involves: 129S/SvEv * C57BL/6J)	increased susceptibility to pharmacologically induced seizures	J:152416
\Asnsd1^{Gt(OST460318)Lex}/\Asnsd1^{Gt(OST460318)Lex} (involves: 129S5/SvEvBrd * C57BL/6J)	environmentally induced seizures	J:320329
\Asp1/\Asp1 (DBA/2J)	audiogenic seizures	J:6355
\Asp2/\Asp2 (DBA/2J)	audiogenic seizures	J:11261, J:5094
\Asp3^DBA/2J/\Asp3^DBA/2J (DBA/2J)	audiogenic seizures	J:11261
\Atp1a3^Myk/\Atp1a3⁺ (B6NCr.129S1-Atp1a3^Myk)	abnormal seizure response to inducing agent	J:180250
\Atp1a3^Myk/\Atp1a3⁺ (B6NCr.129S1-Atp1a3^Myk)	environmentally induced seizures	J:151948
\Atp1a3^Myk/\Atp1a3⁺ (involves: 129S1/SvImJ * C57BL/6J * C57BL/6NCr)	environmentally induced seizures	J:151948
\Atp1a3^tm1.1Tmklh/\Atp1a3⁺ (B6JRj.129S1-Atp1a3^tm1.1Tmklh)	increased susceptibility to pharmacologically induced seizures	J:254463
\Atp1a3^tm1Mika/\Atp1a3⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	abnormal seizure response to inducing agent	J:264408
	increased kindling response	J:264408
\Atp1a3^tm1Ute/\Atp1a3⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	increased kindling response	J:262419
	increased susceptibility to pharmacologically induced seizures	J:262419
\Atp6v1b2^em1Pcamp/\Atp6v1b2⁺ (C57BL/6N-Atp6v1b2^em1Pcamp)	increased susceptibility to pharmacologically induced seizures	J:342781
\Atp6v1b2^em1Pcamp/\Atp6v1b2^em1Pcamp (C57BL/6N-Atp6v1b2^em1Pcamp)	environmentally induced seizures	J:342781
	increased susceptibility to pharmacologically induced seizures	J:342781
\Atp6v1b2^tm1Yoyu/\Atp6v1b2^tm1Yoyu (involves: C57BL/6)	environmentally induced seizures	J:278514
\Avpr1b^tm1Dgen/\Avpr1b^tm1Dgen (involves: 129P2/OlaHsd * C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:101679
\B4galnt1^tm1Rlp/\B4galnt1^tm1Rlp \St8sia1^tm1Rlp/\St8sia1^tm1Rlp (involves: 129S6/SvEvTac)	audiogenic seizures	J:67955
\Baiap3^tm1Smwk/\Baiap3^tm1Smwk (B6N.129P2-Baiap3^tm1Smwk)	increased susceptibility to pharmacologically induced seizures	J:221234
\Bdnf^tm3Jae/\Bdnf^tm3Jae \Tg(Syn1-cre)671Jxm/0 (involves: 129/Sv * C57BL/6 * ICR)	abnormal kindling response	J:91467
\Bhlhe40^tm1.1Rhli/\Bhlhe40^tm1.1Rhli (involves: 129S1/Sv * C57BL/6 * CD-1 * SJL)	increased susceptibility to pharmacologically induced seizures	J:131834
\Bis1^C57BL/6J/? (involves: A/J * C57BL/6J)	abnormal seizure response to pharmacological agent	J:54925
\Bis4^A/J/? (involves: A/J * C57BL/6J)	abnormal seizure response to pharmacological agent	J:54925
\Bsn^tm1Gund/\Bsn^tm1Gund (Not Specified)	increased susceptibility to pharmacologically induced seizures	J:82241
\Cacna1a^tg/\Cacna1a^tg (B6.D2-Cacna1a^tg/J)	increased susceptibility to pharmacologically induced seizures	J:6154
\Cacna1a^tm1.1Sher/\Cacna1a^tm1.1Sher \Tg(Pcp2-cre)2Mpin/0 (involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ)	abnormal seizure response to inducing agent	J:170451
	environmentally induced seizures	J:170451
\Cacna1g^tm1Hssh/\Cacna1g^tm1Hssh (involves: 129S4/SvJae * C57BL/6J)	decreased susceptibility to pharmacologically induced seizures	J:70557
\Cacna2d2^tm1Svi/\Cacna2d2^tm1Svi (involves: 129S1/Sv * C57BL/6J)	increased susceptibility to pharmacologically induced seizures	J:92396
\Car7^tm1.1Kkai/\Car7^tm1.1Kkai (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	environmentally induced seizures	J:200079
\Cdk5r1^tm1Lht/\Cdk5r1^tm1Lht (involves: 129S4/SvJae * C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:38857
\Cdkl5^tm1.2Cogr/Y (involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6J)	abnormal seizure response to inducing agent	J:209635
\Cdkl5^tm1.2Cogr/\Cdkl5^tm1.2Cogr (involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6J)	abnormal seizure response to inducing agent	J:209635
\Cdyl^tm1.1Yuw/\Cdyl^tm1.1Yuw \Emx1^tm1(cre)Yql/\Emx1⁺ (involves: 129S2/SvPas * C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:251551
\Celf4^Ff/\Celf4⁺ (involves: C57BL/6J)	abnormal seizure response to electrical stimulation	J:123744
\Celf4^tm1.1Frk/\Celf4^tm1.1Frk \Emx1^tm1(cre)Krj/? (involves: 129 * C57BL/6J)	increased susceptibility to induction of seizure by inducing agent	J:19671
\Celf4^tm1.1Frk/\Celf4^tm1.1Frk \Tg(Camk2a-cre)1Lfr/0 (involves: 129 * C57BL/6J)	increased susceptibility to induction of seizure by inducing agent	J:194671
\Celf4^tm1.1Frk/\Celf4^tm1.1Frk \Tg(Slc32a1-cre)2.1Hzo/0 (involves: 129 * C57BL/6J * FVB)	decreased susceptibility to induction of seizure by inducing agent	J:194671
\Chrna4^tm1Dra/\Chrna4^tm1Dra (involves: 129S4/SvJae * C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:97020
\Chrna5^tm1Mdb/\Chrna5^tm1Mdb (B6.129-Chrna5^tm1Mdb)	decreased susceptibility to pharmacologically induced seizures	J:89266
\Chrna5^tm1Mdb/\Chrna5^tm1Mdb \Chrnb4^tm1Mdb/\Chrnb4^tm1Mdb (B6.129-Chrnb4^tm1Mdb Chrna5^tm1Mdb)	decreased susceptibility to pharmacologically induced seizures	J:89266
\Chrna7^tm1Bay/\Chrna7^tm1Bay (B6.Cg-Chrna7^tm1Bay)	abnormal seizure response to pharmacological agent	J:74703
\Chrnb2^tm1.1Cont/\Chrnb2⁺ (B6.129-Chrnb2^tm1.1Cont)	increased susceptibility to induction of seizure by inducing agent	J:228269
\Chrnb2^tm1.1Cont/\Chrnb2^tm1.1Cont (B6.129-Chrnb2^tm1.1Cont)	increased susceptibility to induction of seizure by inducing agent	J:228269
\Chrnb4^tm1Mdb/\Chrnb4^tm1Mdb (B6.129-Chrnb4^tm1Mdb)	decreased susceptibility to pharmacologically induced seizures	J:89266
\Cit^tm1Fdc/\Cit^tm1Fdc (either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))	increased susceptibility to pharmacologically induced seizures	J:77297
\Ckb^tm1Bew/\Ckb^tm1Bew (involves: 129P/Ola * C57BL/6)	decreased susceptibility to pharmacologically induced seizures	J:89399
\Clcn3^tm1Lamb/\Clcn3^tm1Lamb (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	decreased susceptibility to pharmacologically induced seizures	J:80901
\Cln3^tm1Blda/\Cln3^tm1Blda (B6.129-Cln3^tm1Blda)	increased susceptibility to pharmacologically induced seizures	J:125194
\Cnr1^tm1.1Ltz/\Cnr1⁺ (involves: 129P2/OlaHsd * C57BL/6N)	increased susceptibility to pharmacologically induced seizures	J:89842
\Cnr1^tm1.1Ltz/\Cnr1^tm1.1Ltz (involves: 129P2/OlaHsd * C57BL/6N)	increased susceptibility to pharmacologically induced seizures	J:89842
\Cnr1^tm1.2Ltz/\Cnr1^tm1.2Ltz (involves: 129P2/OlaHsd * C57BL/6NCrl)	increased susceptibility to pharmacologically induced seizures	J:122066
\Cnr1^tm1.2Ltz/\Cnr1^tm1.2Ltz \Neurod6^tm1(cre)Kan/\Neurod6⁺ (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6NCrl)	increased susceptibility to pharmacologically induced seizures	J:122066
\Cnr1^tm1.2Ltz/\Cnr1^tm1.2Ltz \Tg(Camk2a-cre)2Gsc/0 (involves: 129P2/OlaHsd * C57BL/6N)	increased susceptibility to pharmacologically induced seizures	J:89842
\Cnr1^tm1.2Ltz/\Cnr1^tm1.2Ltz \Tg(Camk2a-cre)2Gsc/? (involves: 129P2/OlaHsd * C57BL/6NCrl * FVB/N)	increased susceptibility to pharmacologically induced seizures	J:122066
\Cnr1^tm2Ltz/\Cnr1^tm2Ltz (B6.Cg-Cnr1^tm2Ltz)	increased susceptibility to pharmacologically induced seizures	J:199647
\Cntn2^tm1Fuka/\Cntn2^tm1Fuka (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:67556
\Cntn5^tm1Kwat/\Cntn5^tm1Kwat (involves: 129X1/SvJ * C57BL/6J)	audiogenic seizures	J:89425
\Cntnap2^tm1Pele/\Cntnap2^tm1Pele (B6.129-Cntnap2^tm1Pele)	environmentally induced seizures	J:177110
\Coq8a^tm1.1Ics/\Coq8a^tm1.1Ics (involves: 129S2/SvPas * C57BL/6J * C57BL/6N)	environmentally induced seizures	J:249129
	increased susceptibility to pharmacologically induced seizures	J:249129
\Cosz1^DBA/2J/\Cosz1^DBA/2J (involves: C57BL/6J * DBA/2J)	abnormal seizure response to pharmacological agent	J:66464
\Cosz2^DBA/2J/\Cosz2^DBA/2J (involves: C57BL/6J * DBA/2J)	abnormal seizure response to pharmacological agent	J:66464
\Cosz3^C57BL/6J/\Cosz3^C57BL/6J (involves: C57BL/6J * DBA/2J)	abnormal seizure response to pharmacological agent	J:66464
\Cosz3^C57BL/6J/\Cosz3^DBA/2J (involves: C57BL/6J * DBA/2J)	abnormal seizure response to pharmacological agent	J:66464
\Crem^tm1.1Endo/\Crem^tm1.1Endo (C57BL/6-Crem^tm1.1Endo)	abnormal kindling response	J:137666
\Ctnnb1^tm2Kem/\Ctnnb1^tm2Kem \Emx1^tm1(cre)Yql/\Emx1⁺ (B6.129-Emx1^tm1(cre)Yql Ctnnb1^tm2Kem)	increased susceptibility to pharmacologically induced seizures	J:92923
\Cul4b^tm1Swl/Y \Edil3^{Tg(Sox2-cre)1Amc}/\Edil3⁺ (B6.Cg-Edil3^{Tg(Sox2-cre)1Amc} Cul4b^tm1Swl)	increased susceptibility to pharmacologically induced seizures	J:187403
\Dbp^tm1Schb/\Dbp^tm1Schb \Hlf^tm1Schb/\Hlf^tm1Schb \Tef^tm1Schb/\Tef^tm1Schb (involves: 129P2/OlaHsd * 129S2/SvPas)	audiogenic seizures	J:90854
\Del(5D5Mit73-D5Mit351)5Jcs/\+ (involves: 129S4/SvJae * C57BL/6J)	maximal tonic hindlimb extension seizures	J:67077
\Del(5D5Mit388-D5Mit351)4Jcs/\+ (involves: 129S4/SvJae * C57BL/6J)	abnormal seizure response to electrical stimulation	J:67077
\Del(5Letm1-D5Mit81)3Jcs/\+ (involves: 129S4/SvJae * C57BL/6J)	abnormal seizure response to electrical stimulation	J:67077
\Del(7Chrna7-Fan1)3Arte/\+ (involves: C57BL/6J * C57BL/6NTac)	abnormal seizure response to electrical stimulation	J:260165
	abnormal seizure response to pharmacological agent	J:260165
	decreased susceptibility to pharmacologically induced seizures	J:260165
\Del(XArmcx5-Nxf3)3Jw/\+ (involves: 129S4/SvJae * C57BL/6 * FVB/N)	environmentally induced seizures	J:210663
\Del(XNxf2-Nxf3)1Jw/\+ (involves: 129S4/SvJae * C57BL/6 * FVB)	audiogenic seizures	J:210663
	environmentally induced seizures	J:210663
\Depdc5^{tm1c(EUCOMM)Hmgu}/\Depdc5^{tm1c(EUCOMM)Hmgu} \Tg(Syn1-cre)671Jxm/0 (involves: C57BL/6N * CBA)	increased susceptibility to pharmacologically induced seizures	J:260943
\Dnm1^Ftfl/\Dnm1⁺ (C57BL/6J-Dnm1^Ftfl)	abnormal kindling response	J:163311
\Dnm1^Ftfl/\Dnm1⁺ (C57BL/6J-Dnm1^Ftfl)	abnormal seizure response to electrical stimulation	J:163311
\Drd2^tm1Ebo/\Drd2^tm1Ebo (involves: 129S2/SvPas * C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:65767
\Dyrk1a^em1Kzy/\Dyrk1a⁺ (C57BL/6J-Dyrk1a^em1Kzy)	environmentally induced seizures	J:259596
\Ecpas^em1Plch/\Ecpas^em1Plch (C57BL/6-Ecpas^em1Plch)	increased susceptibility to pharmacologically induced seizures	J:282974
\Eef1d^tm1.2Mkma/\Eef1d^tm1.2Mkma (B6J.B6N(Cg)-Eef1d^tm1.2Mkma)	audiogenic seizures	J:288930
\Efhc1^tm1Kzy/\Efhc1⁺ (B6.129P2-Efhc1^tm1Kzy)	increased susceptibility to pharmacologically induced seizures	J:145858
\Efhc1^tm1Kzy/\Efhc1^tm1Kzy (B6.129P2-Efhc1^tm1Kzy)	increased susceptibility to pharmacologically induced seizures	J:145858
\Elfn1^tm1.1Jaru/\Elfn1^tm1.1Jaru (involves: C57BL/6)	environmentally induced seizures	J:226212
\Elfn1^tm1.1Jaru/\Elfn1^tm1.1Jaru (involves: C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:226212
\Elfn2^{tm1(KOMP)Vlcg}/\Elfn2^{tm1(KOMP)Vlcg} (C57BL/6NTac-Elfn2^{tm1(KOMP)Vlcg})	audiogenic seizures	J:286127
	increased susceptibility to pharmacologically induced seizures	J:286127
\Elp1^tm1.1Id/\Elp1^tm1.2Id (involves: 129S1/Sv * C57BL/6 * C57BL/6J * CBA)	audiogenic seizures	J:188923
	environmentally induced seizures	J:188923
\Elp1^tm1.2Id/\Elp1^tm1.2Id (involves: 129S1/Sv * C57BL/6 * C57BL/6J * CBA)	audiogenic seizures	J:188923
	environmentally induced seizures	J:188923
\Eml1^heco/\Eml1^heco (involves: NOR)	increased susceptibility to pharmacologically induced seizures	J:208031
\Emx1^{tm1.1(cre)Ito}/\Emx1⁺ \Tg(Gfap-GFAPR239H)60TMIke/0 (involves: 129P2/OlaHsd C57BL/6J)	increased susceptibility to pharmacologically induced seizures	J:139349
\Exq1^A/J/? (involves: A/J * C57BL/6J)	increased susceptibility to pharmacologically induced seizures	J:54925
\Exq1^C57BL/6J/? (involves: A/J * C57BL/6J)	abnormal seizure response to pharmacological agent	J:54925
\Faim2^tm1Dgen/\Faim2^tm1Dgen (involves: 129P2/OlaHsd * C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:101679
\Fcgr2b^tm1Ttk/\Fcgr2b^tm1Ttk (B6.129S4-Fcgr2b^tm1Ttk)	abnormal seizure response to electrical stimulation	J:169028
\Fcgr2b^tm1Ttk/\Fcgr2b^tm1Ttk (B6.129S4-Fcgr2b^tm1Ttk)	maximal tonic hindlimb extension seizures	J:169028
\Fgf7^tm1Efu/\Fgf7^tm1Efu (B6.129-Fgf7^tm1Efu)	increased susceptibility to pharmacologically induced seizures	J:161954
\Fgf13^tm1Jom/\Fgf13⁺ (C57BL/6-Fgf13^tm1Jom)	abnormal kindling response	J:222555
\Fgf13^tm1Jom/\Fgf13⁺ (C57BL/6-Fgf13^tm1Jom)	environmentally induced seizures	J:222555
\Fgf14^tm1Dor/\Fgf14^tm1Dor (129S6/SvEvTac-Fgf14^tm1Dor)	increased susceptibility to pharmacologically induced seizures	J:77806
\Fgf14^tm1Dor/\Fgf14^tm1Dor (B6.129S6-Fgf14^tm1Dor)	increased susceptibility to pharmacologically induced seizures	J:77806
\Fgf22^tm1Dgen/\Fgf22^tm1Dgen (B6.Cg-Fgf22^tm1Dgen)	decreased susceptibility to pharmacologically induced seizures	J:161954
\Fmr1^tm1Cgr/Y (involves: 129P2/OlaHsd * C57BL/6 * FVB/N)	audiogenic seizures	J:127792
\Fmr1^tm1Cgr/Y (either: FVB.129P2(B6)-Fmr1^tm1Cgr/J or FVB;129P2(B6)-Fmr1^tm1Cgr/J)	audiogenic seizures	J:85912
\Fmr1^tm1Cgr/Y \Grm5^tm1Rod/\Grm5⁺ (involves: 129P2/OlaHsd * C57BL/6 * FVB)	audiogenic seizures	J:127792
\Fmr1^tm1Rbd/Y (B6.129-Fmr1^tm1Rbd)	audiogenic seizures	J:155593
\Fosb^tm1Meg/\Fosb^tm1Meg (involves: 129S4/SvJae * 129X1/SvJ)	abnormal seizure response to electrical stimulation	J:110995
\Fyn^tm1Yik/\Fyn^tm1Yik (involves: C57BL/6 * CBA)	audiogenic seizures	J:23384
\Fzd9^tm1Sjp/\Fzd9^tm1Sjp (involves: C57BL/6J)	increased susceptibility to pharmacologically induced seizures	J:99893
\Gabbr1^tm1Bet/\Gabbr1^tm1Bet (BALB/c-Gabbr1^tm1Bet)	audiogenic seizures	J:70558
\Gabra1^tm1.1Geh/\Gabra1⁺ (B6.129(Cg)-Gabra1^tm1.1Geh)	increased susceptibility to pharmacologically induced seizures	J:227437
\Gabra1^tm1.1Mjga/\Gabra1⁺ (B6J.Cg-Gabra1^tm1.1Mjga)	increased susceptibility to pharmacologically induced seizures	J:227437
\Gabra1^tm1.1Uru/\Gabra1^tm1.1Uru (either: 129X1.129P2-Gabra1^tm1.1Uru or B6.129P2-Gabra1^tm1.1Uru)	increased susceptibility to pharmacologically induced seizures	J:75895
\Gabrb3^tm2.1Uru/\Gabrb3^tm2.1Uru (B6J.129S6(Cg)-Gabrb3^tm2.1Uru)	increased susceptibility to pharmacologically induced seizures	J:228332
\Gabrd^tm1.1Jmag/\Gabrd⁺ \Gad2^tm2(cre)Zjh/\Gad2⁺ (involves: 129S4/SvJae * C57BL/6 * SJL)	decreased susceptibility to pharmacologically induced seizures	J:203336
\Gabrg2^tm1.2Rmac/\Gabrg2⁺ (involves: C57BL/6 * C57BL/6J * SJL)	increased susceptibility to pharmacologically induced seizures	J:306976
\Gabrg2^tm1Spet/\Gabrg2⁺ (involves: 129S1/Sv * 129X1/SvJ * BALB/cJ * C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:127120
\Gabrg2^tm1Spet/\Gabrg2⁺ (involves: 129S1/Sv * 129X1/SvJ * BALB/cJ)	increased susceptibility to pharmacologically induced seizures	J:194736
\Gabrg2^tm2Spet/\Gabrg2⁺ (involves: 129S1/Sv * 129X1/SvJ)	decreased susceptibility to pharmacologically induced seizures	J:194196
\Gabrg2^tm2Spet/\Gabrg2⁺ \Tg(Camk2a-tTA)1Mmay/0 \Tg(tetO-cre)LC1Bjd/0 (involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:194736
\Gal^tm1Wyn/\Gal^tm1Wyn (129P2-Gal^tm1Wyn)	increased susceptibility to pharmacologically induced seizures	J:77625
\Gdi1^tm1Ytk/\Gdi1^tm1Ytk (either: (involves: 129X1/SvJ * C57BL/6) or (involves: 129X1/SvJ * C57BL/6 * DBA/2))	increased susceptibility to pharmacologically induced seizures	J:65258
\Gfap^tm2Mes/\Gfap⁺ (involves: 129S6/SvEvTac * 129S7/SvEvBrd * FVB/N)	increased susceptibility to pharmacologically induced seizures	J:114689
\Gfra2^tm1Msa/\Gfra2^tm1Msa (either: (involves: 129S1/Sv * 129S2/SvHsd * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6NHsd))	decreased kindling response	J:53284
\Glra1^tm1.1Geh/\Glra1^tm1.1Geh (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BL/6J * SJL)	increased susceptibility to pharmacologically induced seizures	J:177105
\Glra1^tm2.1Geh/\Glra1^tm2.1Geh (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BL/6J * SJL)	increased susceptibility to pharmacologically induced seizures	J:177106
\Glra3^tm1Dgen/\Glra3^tm1Dgen (involves: 129P2/OlaHsd * C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:101679
\Gnao1^em1Rneu/\Gnao1⁺ (involves: C57BL/6J * C57BL/6NCrl)	increased kindling response	J:271137
\Gnao1^tm2.1Rneu/\Gnao1⁺ (B6.129S-Gnao1^tm2.1Rneu)	abnormal kindling response	J:216850
\Gnb1^em1Dgold/\Gnb1⁺ (C57BL/6NJ-Gnb1^em1Dgold)	minimal clonic seizures	J:346983
\Gng3^tm1.1Rbs/\Gng3^tm1.1Rbs (involves: FVB/N)	audiogenic seizures	J:92791
\Gng3^tm1.1Rbs/\Gng3^tm1.1Rbs (involves: C57BL/6J * FVB/N)	audiogenic seizures	J:92791
\Gng3^tm1.1Rbs/\Gng3^tm1.1Rbs \Gng7^tm1Lex/\Gng7^tm1Lex (B6.Cg-Gng7^tm1Lex Gng3^tm1.1Rbs)	environmentally induced seizures	J:182775
\Gria3^tm1Dgen/Y (involves: 129P2/OlaHsd * C57BL/6)	decreased susceptibility to pharmacologically induced seizures	J:101679
\Gria4^tm1Dgen/\Gria4^tm1Dgen (involves: 129P2/OlaHsd * C57BL/6)	abnormal seizure response to pharmacological agent	J:101679
\Grik2^tm1Bvis/\Grik2^tm1Bvis (129S/Sv-Grik2^tm1Bvis)	increased susceptibility to pharmacologically induced seizures	J:107698
\Grik2^tm1Sfh/\Grik2^tm1Sfh (involves: 129S1/Sv * C57BL/6)	decreased susceptibility to pharmacologically induced seizures	J:46932
\Grik4^tm1(cre)Mim/\Grik4⁺ \Grin1^tm1Mim/\Grin1^tm1Mim (involves: C57BL/6N)	increased susceptibility to pharmacologically induced seizures	J:144994
\Grik5^tm1Dgen/\Grik5^tm1Dgen (involves: 129P2/OlaHsd * C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:101679
\Grin1^tm1Blt/\Grin1^tm1Blt (involves: 129P2/OlaHsd * C57BL/6)	decreased susceptibility to pharmacologically induced seizures	J:62289
\Grin2a^tm1Rsp/\Grin2a^tm1Rsp (involves: 129S1/Sv * 129X1/SvJ)	decreased kindling response	J:45446
\Grm5^tm1Dgen/\Grm5^tm1Dgen (involves: 129P2/OlaHsd * C57BL/6J)	decreased susceptibility to pharmacologically induced seizures	J:82809
	increased susceptibility to pharmacologically induced seizures	J:82809
\Grm7^tm1Betz/\Grm7^tm1Betz (B6.129P2-Grm7^tm1Betz)	increased susceptibility to pharmacologically induced seizures	J:138831
\Grm7^tm1Dgen/\Grm7^tm1Dgen (involves: 129P2/OlaHsd * C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:101679
\Gsg1l^tm1.2Tern/\Gsg1l^tm1.2Tern (C57BL/6J-Gsg1l^tm1.2Tern)	increased susceptibility to pharmacologically induced seizures	J:301313
\Gt(ROSA)26Sor^tm1(Crh)Jde/\Gt(ROSA)26Sor^tm1(Crh)Jde \Tg(Nes-cre)1Kln/0 (involves: 129S2/SvPas * C57BL/6 * SJL)	abnormal seizure response to pharmacological agent	J:140968
\Hcn2^ap/\Hcn2⁺ (DW/Pas-Hcn2^ap)	increased susceptibility to pharmacologically induced seizures	J:146530
\Hcrtr1^tm1Dgen/\Hcrtr1^tm1Dgen (involves: 129P2/OlaHsd * C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:101679
\Hdac4^{Gt(OST361114)Lex}/\Hdac4^{Gt(OST361114)Lex} (involves: 129S5/SvEvBrd * C57BL/6J)	environmentally induced seizures	J:152466
\Hexb^tm1Grv/\Hexb^tm1Grv (either: (involves: 129P2/Ola * C57BL/6J) or (involves: 129S1/Sv * 129X1/SvJ * C57L/6J))	abnormal seizure response to electrical stimulation	J:30899
\Hnrnph2^em1Jpat/Y (C57BL/6J-Hnrnph2^em1Jpat)	audiogenic seizures	J:338313
\Hnrnph2^em1Jpat/\Hnrnph2⁺ (C57BL/6J-Hnrnph2^em1Jpat)	audiogenic seizures	J:338313
\Hnrnph2^em2Jpat/Y (C57BL/6J-Hnrnph2^em2Jpat)	audiogenic seizures	J:338313
\Hnrnph2^em2Jpat/\Hnrnph2^em2Jpat (C57BL/6J-Hnrnph2^em2Jpat)	audiogenic seizures	J:338313
\Hnrnpu^em1Frk/\Hnrnpu⁺ (Not Specified)	maximal tonic hindlimb extension seizures	J:342579
\Hprt1^{tm1(CAG-Glra3)Jcme}/Y \Tg(Camk2a-cre)2Gsc/0 (involves: 129P2/OlaHsd C57BL/6J * FVB/N)	increased susceptibility to pharmacologically induced seizures	J:207981
\Hrh2^tm1Yfks/\Hrh2^tm1Yfks (involves: 129S6/SvEvTac * C57BL/6)	abnormal seizure response to electrical stimulation	J:102252
\Htr1a^tm1Toth/\Htr1a^tm1Toth (involves: 129P2/OlaHsd * Black Swiss)	increased susceptibility to pharmacologically induced seizures	J:66581
\Htr2c^tm1Jul/Y (either: (involves: 129S2/SvPas * C57BL/6J * DBA/2) or (involves: 129S4/SvJae * C57BL/6J * DBA/2))	increased susceptibility to pharmacologically induced seizures	J:24339
\Htr4^tm1Comp/\Htr4^tm1Comp (129/Sv-Htr4^tm1Comp)	increased susceptibility to pharmacologically induced seizures	J:87451
\Htr7^tm1Wtkn/\Htr7^tm1Wtkn (involves: 129S1/Sv * 129X1/SvJ * CD-1)	abnormal seizure response to electrical stimulation	J:124549
	increased susceptibility to pharmacologically induced seizures	J:124549
\Htt^tm1Mem/\Htt^tm6Mem \Tg(CAG-cre/Esr1)5Amc/0 (involves: 129S1/Sv 129X1/SvJ * C57BL/6 * CBA * Swiss Webster)	environmentally induced seizures	J:260244
\Igsf9^tm1Kln/\Igsf9^tm1Kln (involves: 129P2/OlaHsd * C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:209586
\Impa1^tm1Lex/\Impa1^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:157887
\Iqsec2^em1Frk/Y (involves: C3HeB/FeJ * C57BL/6NJ)	decreased susceptibility to induction of seizure by inducing agent	J:284762
\Iqsec2^em1Frk/Y (involves: C3HeB/FeJ * C57BL/6NJ)	decreased susceptibility to pharmacologically induced seizures	J:284762
\Iqsec2^em1Frk/\Iqsec2⁺ (involves: C3HeB/FeJ * C57BL/6NJ)	decreased susceptibility to induction of seizure by inducing agent	J:284762
\Jun^tm2.1Wag/\Jun^tm2.1Wag (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)	decreased susceptibility to pharmacologically induced seizures	J:53481
\Kcna1^tm1Tem/\Kcna1⁺ (involves: 129S7/SvEvBrd * various)	increased susceptibility to pharmacologically induced seizures	J:47349
\Kcna1^tm1Tem/\Kcna1^tm1Tem (involves: 129S7/SvEvBrd * various)	increased susceptibility to pharmacologically induced seizures	J:47349
\Kcna2^tm1Tem/\Kcna2⁺ (C3Fe.129S7-Kcna2^tm1Tem)	increased susceptibility to pharmacologically induced seizures	J:131735
\Kcna2^tm1Tem/\Kcna2^tm1Tem (C3Fe.129S7-Kcna2^tm1Tem)	increased susceptibility to pharmacologically induced seizures	J:131735
\Kcnc2^tm1Rudy/\Kcnc2^tm1Rudy (B6.129S1-Kcnc2^tm1Rudy)	increased susceptibility to pharmacologically induced seizures	J:66730
\Kcnh3^tm1.2Tije/\Kcnh3^tm1.2Tije (involves: C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:165296
\Kcnip1^tm1Zhzh/\Kcnip1^tm1Zhzh (involves: C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:227383
\Kcnj6^tm1Stf/\Kcnj6^tm1Stf (involves: 129S1/Sv * 129X1/SvJ)	environmentally induced seizures	J:38206
	increased susceptibility to pharmacologically induced seizures	J:38206
\Kcnk2^tm1Lzd/\Kcnk2^tm1Lzd (involves: 129 * C57BL/6J)	increased susceptibility to pharmacologically induced seizures	J:91531
\Kcnq2^Nmf134/\Kcnq2⁺ (C57BL/6J-Kcnq2^Nmf134/J)	abnormal seizure response to electrical stimulation	J:82238
\Kcnq2^Nmf134/\Kcnq2⁺ (C57BL/6J-Kcnq2^Nmf134)	abnormal seizure response to electrical stimulation	J:136510
\Kcnq2^Nmf134/\Kcnq2⁺ (C57BL/6J-Kcnq2^Nmf134)	increased susceptibility to pharmacologically induced seizures	J:136510
\Kcnq2^Nmf134/\Kcnq2^Nmf134 (C57BL/6J-Kcnq2^Nmf134/J)	abnormal seizure response to electrical stimulation	J:82238
\Kcnq2^tm1.1Naas/\Kcnq2⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal seizure response to electrical stimulation	J:154582
\Kcnq2^tm1Dgen/\Kcnq2⁺ (involves: 129P2/OlaHsd * C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:101679
\Kcnq2^tm1Hsa/\Kcnq2⁺ (involves: 129P2/OlaHsd * C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:62797
\Kcnq3^tm1.1Naas/\Kcnq3⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal seizure response to electrical stimulation	J:154582
\Kcnq3^tm1.1Naas/\Kcnq3⁺ (involves: 129S1/Sv * 129X1/SvJ * FVB/N)	abnormal seizure response to electrical stimulation	J:154582
\Kcnt1^em1Lekk/\Kcnt1⁺ (C57BL/6J-Kcnt1^em1Lekk)	increased susceptibility to pharmacologically induced seizures	J:287751
\Kcnt1^tm1.2Acsc/\Kcnt1^tm1.2Acsc (involves: 129 * C57BL/6N)	abnormal seizure response to electrical stimulation	J:287751
\Kdm1a^tm1Ebg/\Kdm1a^tm1Ebg (B6.129-Kdm1a^tm1Ebg)	decreased susceptibility to pharmacologically induced seizures	J:235553
\Kif4^em1Noh/Y (C57BL/6J-Kif4^em1Noh)	increased susceptibility to pharmacologically induced seizures	J:336792
\Klk8^tm1Lth/\Klk8^tm1Lth (involves: 129P2/OlaHsd * C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:71533
\L2hgdh^{Gt(DC0625)Wtsi}/\L2hgdh^{Gt(DC0625)Wtsi} (involves: 129P2/OlaHsd * C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:228407
\Lamp5^em1Lmit/\Lamp5⁺ (C57BL/6-Lamp5^em1Lmit)	increased susceptibility to pharmacologically induced seizures	J:345459
\Lamp5^em1Lmit/\Lamp5^em1Lmit (C57BL/6-Lamp5^em1Lmit)	increased susceptibility to pharmacologically induced seizures	J:345459
\Letm1^{Gt(CC0204)Wtsi}/\Letm1⁺ (129S.129P2-Letm1^{Gt(CC0204)Wtsi})	increased susceptibility to pharmacologically induced seizures	J:222017
\Letm1^{Gt(DD0926)Wtsi}/\Letm1⁺ (129S.129P2-Letm1^{Gt(DD0926)Wtsi})	increased susceptibility to pharmacologically induced seizures	J:222017
\Lgi1^tm1.1Ics/\Lgi1⁺ (involves: 129S2/SvPas * BALB/c * C57BL/6)	audiogenic seizures	J:182795
\Lgi1^tm1.1Ics/\Lgi1^tm1.1Ics (involves: 129S2/SvPas * BALB/c * C57BL/6)	environmentally induced seizures	J:182795
\Lgi1^tm1Mafu/\Lgi1⁺ (involves: 129S6/SvEvTac * C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:157578
\Lhx6^tm1Vpa/\Lhx6^tm2Vpa (involves: 129P2/OlaHsd * C57BL/6)	environmentally induced seizures	J:198547
	increased susceptibility to pharmacologically induced seizures	J:198547
\Lrrc4b^tm1Lex/\Lrrc4b^tm1Lex (involves: 129S/SvEv * C57BL/6J)	increased susceptibility to pharmacologically induced seizures	J:276446
\Mapk10^tm1Flv/\Mapk10^tm1Flv (involves: 129S1/Sv)	decreased susceptibility to pharmacologically induced seizures	J:43658
\Mapt^tm1Hnd/\Mapt⁺ (involves: 129X1/SvJ * C57BL/6)	decreased susceptibility to pharmacologically induced seizures	J:121330
\Mapt^tm1Hnd/\Mapt⁺ \Zbtb20^{Tg(PDGFB-APPSwInd)20Lms}/0 (involves: 129X1/SvJ * C57BL/6 * DBA/2)	decreased susceptibility to pharmacologically induced seizures	J:121330
\Mapt^tm1Hnd/\Mapt^tm1Hnd (involves: 129X1/SvJ * C57BL/6)	decreased susceptibility to pharmacologically induced seizures	J:121330
\Mapt^tm1Hnd/\Mapt^tm1Hnd \Zbtb20^{Tg(PDGFB-APPSwInd)20Lms}/0 (involves: 129X1/SvJ * C57BL/6 * DBA/2)	decreased susceptibility to pharmacologically induced seizures	J:121330
\Mbnl2^tm1.1Sws/\Mbnl2⁺ (involves: 129S1/SvImJ * BALB/cJ * C57BL/6J)	increased susceptibility to pharmacologically induced seizures	J:218010
\Mbnl2^tm1.1Sws/\Mbnl2^tm1.1Sws (involves: 129S1/SvImJ * BALB/cJ * C57BL/6J)	increased susceptibility to pharmacologically induced seizures	J:218010
\Mbp^jve/\Mbp^jve (involves: C57BL/6J)	environmentally induced seizures	J:221049
\Mbp^shi/\Mbp^shi (involves: C3H * ICR * SWV)	audiogenic seizures	J:6578
\Mbp^shi/\Mbp^shi (involves: C3H * ICR * SWV)	environmentally induced seizures	J:6578
\Mbp^shi/\Mbp^shi \Tg(Thy1-YFP)HJrs/0 (involves: C3HeB/Fe * C57BL/6 * CBA * SWV)	increased susceptibility to pharmacologically induced seizures	J:158545
\Mc2r^tm1Dgen/\Mc2r^tm1Dgen (involves: 129P2/OlaHsd * C57BL/6J)	increased susceptibility to pharmacologically induced seizures	J:82809
\Mecp2^em1Jlzn/Y (C57BL/6-Mecp2^em1Jlzn)	environmentally induced seizures	J:296009
\Mecp2^tm3Meg/Y (B6.129-Mecp2^tm3Meg)	increased susceptibility to pharmacologically induced seizures	J:204723
\Mt1^tm1Bri/\Mt1^tm1Bri \Mt2^tm1Bri/\Mt2^tm1Bri (129S7/SvEvBrd-Mt1^tm1Bri Mt2^tm1Bri/J)	increased susceptibility to pharmacologically induced seizures	J:89429
\Mt3^tm1Rpa/\Mt3^tm1Rpa (involves: 129S7/SvEvBrd * C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:38222
\Mvp^{Gt(IST10954E2)Tigm}/\Mapk3^tm1Gpg (involves: 129 * C57BL/6J * C57BL/6N)	decreased susceptibility to pharmacologically induced seizures	J:343325
\n-TRtct5^m1J/\n-TRtct5^m1J (C57BL/6J)	abnormal seizure response to electrical stimulation	J:297745
\n-TRtct5^m1J/\n-TRtct5^m1J (C57BL/6J)	abnormal seizure response to pharmacological agent	J:297745
\n-TRtct5^tm1.1Slac/\n-TRtct5^tm1.1Slac (C57BL/6J-n-TRtct5^tm1.1Slac)	abnormal seizure response to electrical stimulation	J:297745
	abnormal seizure response to pharmacological agent	J:297745
\n-TRtct5^tm2.1Slac/\n-TRtct5^tm2.1Slac (C57BL/6NJ-n-TRtct5^tm2.1Slac)	abnormal seizure response to pharmacological agent	J:297745
\Ndufs4^tm1.1Rpa/\Ndufs4^tm1.1Rpa (involves: 129S4/SvJaeSor)	environmentally induced seizures	J:161393
\Ndufs4^tm1Rpa/\Ndufs4^tm1Rpa \Tg(Nes-cre)1Kln/0 (involves: 129S4/SvJaeSor * C57BL/6 * SJL)	environmentally induced seizures	J:161393
\Neurod2^tm1Tap/\Neurod2^tm1Tap (involves: 129/Sv * C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:69606
\Nhlrc1^{tm1(KOMP)Vlcg}/\Nhlrc1^{tm1(KOMP)Vlcg} (involves: C57BL/6J * C57BL/6NTac)	increased susceptibility to pharmacologically induced seizures	J:218959
\Nhlrc1^{tm1(KOMP)Vlcg}/\Nhlrc1^{tm1(KOMP)Vlcg} (involves: C57BL/6NTac)	abnormal seizure response to electrical stimulation	J:210491
	abnormal seizure response to pharmacological agent	J:210491
\Nhlrc1^{tm1(KOMP)Vlcg}/\Nhlrc1^{tm1(KOMP)Vlcg} \Gys1^{tm1c(EUCOMM)Wtsi}/\Gys1⁺ \Tg(Nes-cre)1Kag/? (involves: C57BL/6NTac)	abnormal seizure response to electrical stimulation	J:210491
	abnormal seizure response to pharmacological agent	J:210491
\Nhlrc1^{tm1(KOMP)Vlcg}/\Nhlrc1^{tm1(KOMP)Vlcg} \Gys1^{tm1c(EUCOMM)Wtsi}/\Gys1^{tm1c(EUCOMM)Wtsi} \Tg(Nes-cre)1Kag/? (involves: C57BL/6NTac)	abnormal seizure response to electrical stimulation	J:210491
	abnormal seizure response to pharmacological agent	J:210491
\Nmf31/\Nmf31⁺ (BALB/cByJ-Nmf31/J)	minimal clonic seizures	J:78134
\nmf88/\nmf88 (C57BL/6J-nmf88/J)	abnormal seizure response to electrical stimulation	J:82238
\Nos1^tm1Plh/\Nos1^tm1Plh (B6.129S4-Nos1^tm1Plh)	abnormal seizure response to inducing agent	J:107964
\Nos2^tm1Lau/\Nos2^tm1Lau (B6.129P2-Nos2^tm1Lau)	increased susceptibility to pharmacologically induced seizures	J:107300
\Nos3^tm1Plh/\Nos3^tm1Plh (B6.129S4-Nos3^tm1Plh)	abnormal seizure response to inducing agent	J:107964
\Npy2r^tm1.1Hhz/\Npy2r^tm1.1Hhz (involves: 129X1/SvJ * C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:124729
\Npy^tm1Rpa/\Npy^tm1Rpa (involves: 129S7/SvEvBrd)	increased susceptibility to pharmacologically induced seizures	J:33261
\Npy^tm2Rpa/\Npy^tm2Rpa (involves: 129S4/SvJaeSor * C57BL/6)	decreased susceptibility to pharmacologically induced seizures	J:104699
\Nr4a3^tm1Omc/\Nr4a3^tm1Omc (involves: 129S/SvEv * C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:93320
\Nrp2^tm1.2Mom/\Nrp2⁺ (involves: 129P2/OlaHsd * C57BL/6 * FVB/NJ)	environmentally induced seizures	J:166116
	increased susceptibility to pharmacologically induced seizures	J:166116
\Nrp2^tm1.2Mom/\Nrp2^tm1.2Mom (involves: 129P2/OlaHsd * C57BL/6 * FVB/NJ)	environmentally induced seizures	J:166116
	increased susceptibility to pharmacologically induced seizures	J:166116
\Ntrk2^tm1Jom/\Ntrk2⁺ \Tg(Syn1-cre)671Jxm/0 (involves: 129/Sv * C57BL/6 * ICR)	decreased kindling response	J:91467
\Ntrk2^tm1Jom/\Ntrk2^tm1Jom \Tg(Syn1-cre)671Jxm/0 (involves: 129/Sv * C57BL/6 * ICR)	decreased kindling response	J:91467
\Oprd1^tm1Dgen/\Oprd1^tm1Dgen (involves: 129P2/OlaHsd * C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:101679
\P2rx6^tm1Dgen/\P2rx6^tm1Dgen (involves: 129P2/OlaHsd * C57BL/6J)	decreased susceptibility to pharmacologically induced seizures	J:82809
\Pah^m1Btlr/\Pah^m1Btlr (C57BL/6J-Pah^m1Btlr)	audiogenic seizures	J:152890
\Pah^m1Btlr/\Pah^m1Btlr (C57BL/6J-Pah^m1Btlr)	environmentally induced seizures	J:152890
\Panx1^tm1.1Fama/\Panx1^tm1.1Fama (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased susceptibility to pharmacologically induced seizures	J:177671
\Panx1^{tm1a(KOMP)Wtsi}/\Panx1^{tm1a(KOMP)Wtsi} (involves: C57BL/6 * C57BL/6N)	decreased susceptibility to pharmacologically induced seizures	J:177671
\Pcmt1^tm1Scl/\Pcmt1^tm1Scl (involves: 129S4/SvJae * C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:40967
\Pde8a^tm1Dgen/\Pde8a^tm1Dgen (involves: 129P2/OlaHsd * C57BL/6J)	increased susceptibility to pharmacologically induced seizures	J:82809
\Pdyn^tm1(cre)Czer/\Pdyn⁺ (B6.Cg-Pdyn^tm1(cre)Czer)	increased susceptibility to pharmacologically induced seizures	J:122651
\Pdyn^tm1(cre)Czer/\Pdyn^tm1(cre)Czer (B6.Cg-Pdyn^tm1(cre)Czer)	increased susceptibility to pharmacologically induced seizures	J:122651
\Phf6^em1Azbi/Y (B6.Cg-Phf6^em1Azbi)	increased susceptibility to pharmacologically induced seizures	J:271089
\Pis1^A/J/\Pis1^A/J (C57BL/6J-Chr 10^A/J/NaJ)	increased susceptibility to pharmacologically induced seizures	J:118211
\Pis2^A/J/\Pis2^A/J (C57BL/6J-Chr 18^A/J/NaJ)	increased susceptibility to pharmacologically induced seizures	J:118211
\Plaur^tm1Mlg/\Plaur^tm1Mlg (B6.Cg-Plaur^tm1Mlg)	increased susceptibility to pharmacologically induced seizures	J:81735
\Plcb1^tm1Hssh/\Plcb1^tm1Hssh (Not Specified)	increased susceptibility to pharmacologically induced seizures	J:43077
\Plcl1^tm1Mh/\Plcl1^tm1Mh (involves: 129/Sv * C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:92956
\Plp1^jp/Y (Not Specified)	environmentally induced seizures	J:288
\Plppr5^em2Gpt/\Plppr5^em2Gpt (C57BL/6-Plppr5^em2Gpt)	increased susceptibility to pharmacologically induced seizures	J:324004
\Ppp1r9b^tm1Jfe/\Ppp1r9b^tm1Jfe (involves: 129X1/SvJ * C57BL/6)	decreased susceptibility to pharmacologically induced seizures	J:77284
\Prickle1^em1Yzou/\Prickle1⁺ (C57BL/6-Prickle1^em1Yzou)	increased susceptibility to pharmacologically induced seizures	J:321396
\Prickle1^m1Ingm/\Prickle1⁺ (involves: C57BL/6)	abnormal seizure response to electrical stimulation	J:169136
\Prickle1^m2Ingm/\Prickle1⁺ (C57BL/6-Prickle1^m2Ingm)	abnormal seizure response to electrical stimulation	J:169136
\Prickle1^tm1Nue/\Prickle1⁺ (B6.Cg-Prickle1^tm1Nue)	abnormal seizure response to electrical stimulation	J:169136
\Prickle2^tm1Nue/\Prickle2⁺ (B6.Cg-Prickle2^tm1Nue)	abnormal seizure response to electrical stimulation	J:169136
\Prickle2^tm1Nue/\Prickle2^tm1Nue (B6.Cg-Prickle2^tm1Nue)	abnormal seizure response to electrical stimulation	J:169136
\Prickle2^tm1Nue/\Prickle2^tm1Nue (B6.Cg-Prickle2^tm1Nue)	increased susceptibility to pharmacologically induced seizures	J:169136
\Prrt2^{tm1a(KOMP)Wtsi}/\Prrt2^{tm1a(KOMP)Wtsi} (C57BL/6N-A^tm1Brd Prrt2^{tm1a(KOMP)Wtsi}/Wtsi)	audiogenic seizures	J:237823
	increased susceptibility to pharmacologically induced seizures	J:237823
\Ptgs2^tm1Unc/\Ptgs2^tm1Unc (B6;129P2-Ptgs2^tm1Unc/Tac)	increased susceptibility to pharmacologically induced seizures	J:141610
\Ptpro^tm1Dgen/\Ptpro^tm1Dgen (involves: 129P2/OlaHsd * C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:101679
\Rbfox1^tm1.1Dblk/\Rbfox1⁺ \Tg(Nes-cre)1Kln/0 (involves: 129S2/SvPas * 129S4/SvJaeSor * C57BL/6 * C57BL/6J * SJL)	increased susceptibility to pharmacologically induced seizures	J:176189
\Rbfox1^tm1.1Dblk/\Rbfox1^tm1.1Dblk \Tg(Nes-cre)1Kln/0 (involves: 129S2/SvPas * 129S4/SvJaeSor * C57BL/6 * C57BL/6J * SJL)	increased susceptibility to pharmacologically induced seizures	J:176189
\Rbfox3^{tm1a(EUCOMM)Hmgu}/\Rbfox3^{tm1a(EUCOMM)Hmgu} (B6Dnk;B6N-Rbfox3^{tm1a(EUCOMM)Hmgu}/H)	increased susceptibility to pharmacologically induced seizures	J:234043
\Rogdi^tm1.2Ics/\Rogdi^tm1.2Ics (involves: C57BL/6N)	increased susceptibility to pharmacologically induced seizures	J:344072
\Ryr2^tm1Slh/\Ryr2⁺ (involves: 129S7/SvEvBrd * C57BL/6J)	increased susceptibility to pharmacologically induced seizures	J:235432
\Ryr2^tm2Amks/\Ryr2⁺ (B6.129-Ryr2^tm2Amks)	increased susceptibility to pharmacologically induced seizures	J:137696
\Ryr2^tm2Amks/\Ryr2^tm2Amks (B6.129-Ryr2^tm2Amks)	increased susceptibility to pharmacologically induced seizures	J:137696
\Scamp5^tm1Smoc/\Scamp5^tm1Smoc (involves: C57BL/6J)	audiogenic seizures	J:288324
\Scn1a^em1Anord/\Scn1a⁺ (C57BL/6N-Scn1a^em1Anord)	environmentally induced seizures	J:333350
\Scn1a^em1Anord/\Scn1a⁺ (C57BL/6N-Scn1a^em1Anord)	increased susceptibility to pharmacologically induced seizures	J:333350
\Scn1a^em1Anord/\Scn1a^em1Anord (C57BL/6N-Scn1a^em1Anord)	environmentally induced seizures	J:333350
\Scn1a^tm1.1Aesc/\Scn1a⁺ (involves: 129X1/SvJ * C57BL/6J * SJL)	environmentally induced seizures	J:161191
	increased susceptibility to pharmacologically induced seizures	J:161191
\Scn1a^tm1.1Aesc/\Scn1a⁺ (involves: 129S6/SvEvTac * 129X1/SvJ * C57BL/6J)	increased susceptibility to pharmacologically induced seizures	J:170734
\Scn1a^tm1.1Aesc/\Scn1a^tm1.1Aesc (involves: 129X1/SvJ * C57BL/6J * SJL)	environmentally induced seizures	J:161191
	maximal tonic hindlimb extension seizures	J:161191
\Scn1a^tm1.1Kzy/\Scn1a⁺ (involves: 129P2/OlaHsd * C3HeB/FeJ * C57BL/6J)	increased susceptibility to pharmacologically induced seizures	J:209093
\Scn1a^tm1.1Kzy/\Scn1a⁺ (involves: 129P2/OlaHsd * C3HeB/FeJ)	environmentally induced seizures	J:260796
\Scn1a^tm1.1Swl/\Scn1a⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6JNarl)	environmentally induced seizures	J:221045
\Scn1a^tm1Wac/\Scn1a⁺ (involves: 129S1/Sv * 129X1/SvJ * FVB/NJ)	increased susceptibility to pharmacologically induced seizures	J:129998
\Scn1a^tm2.1Wac/\Scn1a⁺ \Tg(I12b-cre)1Jlr/0 (involves: C57BL/6J * CD-1)	environmentally induced seizures	J:189897
\Scn1b^tm1.1Bion/\Scn1b⁺ (Not Specified)	environmentally induced seizures	J:163771
\Scn1b^tm1.1Bion/\Scn1b^tm1.1Bion (Not Specified)	environmentally induced seizures	J:163771
\Scn2b^tm1Isom/\Scn2b^tm1Isom (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	increased susceptibility to pharmacologically induced seizures	J:82050
\Scn8a^med-jo/\Scn8a⁺ (B6.D2-Scn8a^med-jo/J)	decreased susceptibility to pharmacologically induced seizures	J:170734, J:129998
\Scn8a^med/\Scn8a⁺ (C3Fe.Cg-Scn8a^med/J)	decreased susceptibility to pharmacologically induced seizures	J:129998
\Scn9a^tm1.1Naas/\Scn9a^tm1.1Naas (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	abnormal seizure response to electrical stimulation	J:154118
	minimal clonic seizures	J:154118
\Scn9a^tm1.1Naas/\Scn9a^tm1.1Naas (B6.129-Scn9a^tm1.1Naas)	abnormal kindling response	J:154118
\Senp2^tm1Eyeh/\Senp2^tm1Eyeh (Not Specified)	audiogenic seizures	J:217910
\Serpine2^tm1Dmn/\Serpine2^tm1Dmn (involves: 129P2/OlaHsd * C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:40953
\Sez6^tm1.1Sest/\Sez6^tm1.1Sest (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	decreased susceptibility to pharmacologically induced seizures	J:132725
\Shank3^tm1.1Cya/\Shank3^tm1.1Cya (B6.Cg-Shank3^tm1.1Cya)	decreased susceptibility to pharmacologically induced seizures	J:281328
\Shank3^tm2Gfng/\Shank3^tm2Gfng (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	environmentally induced seizures	J:171113
\Sicd1^C57BL/6J/\Sicd1^C57BL/6J (FVB.B6-(D18Mit141-D18Mit25))	increased susceptibility to pharmacologically induced seizures	J:122922
\sims/\sims (B6.Cg-sims/GrsrJ)	audiogenic seizures	J:161505
\sims/\sims⁺ (B6.Cg-sims/GrsrJ)	environmentally induced seizures	J:161505
\Sipa1l1^tm1Taki/\Sipa1l1^tm1Taki (B6.Cg-Sipa1l1^tm1Taki/Taki)	increased susceptibility to pharmacologically induced seizures	J:345320
\Slc1a2^tm1Kta/\Slc1a2^tm1Kta (involves: 129P2/OlaHsd * C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:40984
\Slc1a3^tm1Kta/\Slc1a3^tm1Kta (involves: 129P2/OlaHsd)	abnormal kindling response	J:58180
\Slc1a3^tm1Kta/\Slc1a3^tm1Kta (involves: 129P2/OlaHsd)	increased susceptibility to pharmacologically induced seizures	J:58180
\Slc2a1^Rgsc200/\Slc2a1⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	environmentally induced seizures	J:281292
\Slc4a3^tm1Cahb/\Slc4a3^tm1Cahb (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:104157
\Slc4a10^tm1.1Cahb/\Slc4a10^tm1.1Cahb (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased susceptibility to pharmacologically induced seizures	J:131058
\Slc6a11^tm1Dgen/\Slc6a11⁺ (involves: 129P2/OlaHsd * C57BL/6)	decreased susceptibility to pharmacologically induced seizures	J:101679
\Slc7a8^tm1Dgen/\Slc7a8^tm1Dgen (involves: 129P2/OlaHsd * C57BL/6)	decreased susceptibility to pharmacologically induced seizures	J:101679
\Slc9a6^tm1Dgen/Y (involves: 129P2/OlaHsd * C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:101679
\Slc10a4^tm1Tigm/\Slc10a4^tm1Tigm (involves: 129S/SvEvBrd)	increased susceptibility to pharmacologically induced seizures	J:196996
\Slc12a5^tm1Dlp/\Slc12a5⁺ (involves: C57BL/6J)	increased susceptibility to pharmacologically induced seizures	J:113307
\Slc12a5^tm1Hsav/\Slc12a5^tm2Hsav (involves: 129S1/Sv * 129S2/SvPasHsd * 129X1/SvJ * C57BL/6J * C57BL/6JOlaHsd)	increased susceptibility to pharmacologically induced seizures	J:101079
\Slc12a6^tm1Tjj/\Slc12a6^tm1Tjj (involves: 129/Sv * C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:86183
\Slc17a5^tm1Lex/\Slc17a5^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6)	environmentally induced seizures	J:158444
\Slc18a3^tm1Mca/\Slc18a3^tm1Mca (involves: 129S4/SvJae * C57BL/6J)	increased susceptibility to pharmacologically induced seizures	J:136620
\Slc32a1^tm2(cre)Lowl/\Slc32a1^tm2(cre)Lowl (either: B6J.129S6(FVB)-Slc32a1^tm2(cre)Lowl or (involves: 129S6/SvEvTac * C57BL/6J * FVB/N))	increased kindling response	J:308516
\Slitrk3^tm1Jaru/\Slitrk3^tm1Jaru (involves: 129P2/OlaHsd * C57BL/6J)	increased susceptibility to pharmacologically induced seizures	J:232385
\St3gal4^tm1.1Bsi/\St3gal4^tm1.1Bsi (B6J.B6N-St3gal4^tm1.1Bsi)	decreased kindling response	J:217104
\Stam^tm1Sug/\Stam^tm1Sug (involves: 129S4/SvJae * C57BL/6)	increased susceptibility to pharmacologically induced seizures	J:69504
\Syn1^tm1Pggd/\Syn1^tm1Pggd (involves: 129)	abnormal seizure response to electrical stimulation	J:29086
\Syn1^tm1Pggd/\Syn1^tm1Pggd \Syn2^tm1Pggd/\Syn2^tm1Pggd \Syn3^tm1Pggd/\Syn3^tm1Pggd (involves: 129 * 129P2/OlaHsd * 129X1/SvJ * C57BL/6)	environmentally induced seizures	J:175256
\Syngap1^tm1Rlh/\Syngap1⁺ (involves: 129S1/Sv * 129X1/SvJ)	audiogenic seizures	J:193208
\Syngap1^tm1Rlh/\Syngap1⁺ (involves: 129S1/Sv * 129X1/SvJ)	increased susceptibility to pharmacologically induced seizures	J:193208
\Szs1^C57BL/6J/\Szs1^DBA/2J (involves: C57BL/6J * DBA/2J)	abnormal seizure response to pharmacological agent	J:56630
\Szs1^DBA/2J/\Szs1^DBA/2J (involves: C57BL/6J * DBA/2J)	abnormal seizure response to pharmacological agent	J:56630
\Szs1^DBA/2J/\Szs1^DBA/2J (involves: B6.D2-Mtv7^a/Ty)	abnormal seizure response to electrical stimulation	J:70295
\Szs1^DBA/2J/\Szs1^DBA/2J (involves: B6.D2-Mtv7^a/Ty * C57BL/6J)	abnormal seizure response to electrical stimulation	J:89732
\Szs2^C57BL/6J/\Szs2^C57BL/6J (involves: C57BL/6J * DBA/2J)	abnormal seizure response to electrical stimulation	J:38888
\Szs2^C57BL/6J/\Szs2^DBA/2J (involves: C57BL/6J * DBA/2J)	abnormal seizure response to electrical stimulation	J:38888
\Szs5^DBA/2J/? (involves: C57BL/6J * DBA/2J)	abnormal seizure response to pharmacological agent	J:56630
\Szs6^C57BL/6J/? (involves: C57BL/6J * DBA/2J)	abnormal seizure response to pharmacological agent	J:56630
\Szs7^DBA/2J/? (involves: C57BL/6J * DBA/2J)	abnormal seizure response to electrical stimulation	J:70295
\Szs8^DBA/2J/\Szs8^C57BL/6J (involves: C57BL/6J * DBA/2J)	abnormal seizure response to electrical stimulation	J:70295
\Szs8^DBA/2J/\Szs8^DBA/2J (involves: C57BL/6J * DBA/2J)	abnormal seizure response to electrical stimulation	J:70295
\Szs9^C57BL/6J/\Szs9^DBA/2J (involves: C57BL/6J * DBA/2J)	abnormal seizure response to electrical stimulation	J:70295
\Szs9^DBA/2J/\Szs9^DBA/2J (involves: C57BL/6J * DBA/2J)	abnormal seizure response to electrical stimulation	J:70295
\Szs10^C57BL/6J/\Szs10^C57BL/6J (involves: B6.D2-Mtv7^a/Ty)	abnormal seizure response to electrical stimulation	J:70295
\Szs10^C57BL/6J/\Szs10^DBA/2J (involves: B6.D2-Mtv7^a/Ty)	abnormal seizure response to electrical stimulation	J:70295
\Szs11^C57BL/6J/\Szs11^C57BL/6J (D2.B6-(D5Mit345-D5Mit403))	abnormal seizure response to electrical stimulation	J:129499
\Szs11^DBA/2J/\Szs11^C57BL/6J (involves: B6.D2-Mtv7^a/Ty)	abnormal seizure response to electrical stimulation	J:70295
\Szs11^DBA/2J/\Szs11^DBA/2J (involves: B6.D2-Mtv7^a/Ty)	abnormal seizure response to electrical stimulation	J:70295
\Szs11^DBA/2J/\Szs11^DBA/2J (B6.D2-(D5Mit75-D5Mit403))	abnormal seizure response to electrical stimulation	J:129499
\Szs12^DBA/2J/\Szs12^C57BL/6J (involves: B6.D2-Mtv7^a/Ty)	abnormal seizure response to electrical stimulation	J:70295
\Szs12^DBA/2J/\Szs12^DBA/2J (involves: B6.D2-Mtv7^a/Ty)	abnormal seizure response to electrical stimulation	J:70295
\Szs13^DBA/2J/\Szs13^C57BL/6J (involves: B6.D2-Mtv7^a/Ty)	abnormal seizure response to electrical stimulation	J:70295
\Szs13^DBA/2J/\Szs13^DBA/2J (involves: B6.D2-Mtv7^a/Ty)	abnormal seizure response to electrical stimulation	J:70295
\Szt1/\Szt1⁺ (involves: BALB/cByJ * BALB/cJ * C57BL/6J)	abnormal seizure response to electrical stimulation	J:82964
\Szt1/\Szt1⁺ (involves: BALB/cByJ * BALB/cJ * C57BL/6J)	abnormal seizure response to pharmacological agent	J:82964
\Szt1/\Szt1⁺ (C57BL/6J-Szt1)	abnormal seizure response to electrical stimulation	J:136510
\Szt2^Gt(XH662)Byg/\Szt2⁺ (involves: 129P2/OlaHsd * C57BL/6J)	minimal clonic seizures	J:150942
\Szt2^Gt(XH662)Byg/\Szt2^Gt(XH662)Byg (129S1.129P2(B6)-Szt2^Gt(XH662)Byg/FrkJ)	maximal tonic hindlimb extension seizures	J:150942
	minimal clonic seizures	J:150942
\Szt2^Gt(XH662)Byg/\Szt2^m1Frk (involves: 129P2/OlaHsd * C57BL/6J)	minimal clonic seizures	J:150942
\Szt2^m1Frk/\Szt2^m1Frk (C57BL/6J-Szt2^m1Frk)	abnormal kindling response	J:150942
\Szt2^m1Frk/\Szt2^m1Frk (C57BL/6J-Szt2^m1Frk)	minimal clonic seizures	J:150942
\Szt2^m1Frk/\Szt2^m1Frk (involves: BALB/cByJ * C57BL/6J)	increased susceptibility to pharmacologically induced seizures	J:150942
\Szt2^m1Frk/\Szt2^m1Frk (involves: BALB/cByJ * C57BL/6J)	minimal clonic seizures	J:150942
\Szv1^C57BL/6J/\Szv1^C57BL/6J (involves: C57BL/6J * DBA/2J)	abnormal seizure response to pharmacological agent	J:38888
\Szv2^C57BL/6J/\Szv2^C57BL/6J (involves: C57BL/6J * DBA/2J)	abnormal seizure response to pharmacological agent	J:38888
\Szv2^C57BL/6J/\Szv2^DBA/2J (involves: C57BL/6J * DBA/2J)	abnormal seizure response to pharmacological agent	J:38888
\Szv3^C57BL/6J/\Szv3^DBA/2J (involves: C57BL/6J * DBA/2J)	abnormal seizure response to pharmacological agent	J:70295
\Szv3^DBA/2J/\Szv3^DBA/2J (involves: C57BL/6J * DBA/2J)	abnormal seizure response to pharmacological agent	J:70295
\Tecta^tm3.1Gpr/\Tecta⁺ (involves: 129S/SvEv)	audiogenic seizures	J:203482
\Tecta^tm4.1Gpr/\Tecta⁺ (involves: 129S/SvEv)	audiogenic seizures	J:203482
\Tecta^tm5.1Gpr/\Tecta⁺ (involves: 129S/SvEv)	audiogenic seizures	J:203482
\Tg(CAG-cre/Esr1)5Amc/0 \Ube3a^tm1Yelg/\Ube3a⁺ (involves: 129P2/OlaHsd 129S2/SvPasCrl * C57BL/6J)	audiogenic seizures	J:222400
\Tg(Camk2a-Bdnf)A9Stl/0 (C57BL/6-Tg(Camk2a-Bdnf)A9Stl/J)	psychomotor seizures	J:216846
\Tg(Camk2a-Crem)I15Endo/0 (involves: C3H * C57BL/6)	abnormal kindling response	J:137666
\Tg(Camk2a-Crem)IIEndo/0 (C57BL/6-Tg(Camk2a-Crem)IIEndo/EndoRbrc)	abnormal kindling response	J:137666
\Tg(Camk2a-Fyn-531)1Nko/0 (involves: 129S7/SvEvBrd * C57BL/6 * CBA)	abnormal kindling response	J:59490
	abnormal seizure response to electrical stimulation	J:59490
	increased susceptibility to pharmacologically induced seizures	J:59490
\Tg(Camk2a-tTA)1Mmay/0 \Tg(tetO-MAPT)32Lms/0 (B6.Cg-Tg(Camk2a-tTA)1Mmay Tg(tetO-MAPT)32Lms)	increased susceptibility to pharmacologically induced seizures	J:233816
\Tg(Camk2a-tTA)1Mmay/0 \Tg(tetO-MAPTA152T)L1Lms/0 (B6.Cg-Tg(Camk2a-tTA)1Mmay Tg(tetO-MAPTA152T)L1Lms)	increased susceptibility to pharmacologically induced seizures	J:233816
\Tg(DBH-Gal)1923Stei/0 (B6.Cg-Tg(DBH-Gal)1923Stei)	decreased susceptibility to pharmacologically induced seizures	J:77625
\Tg(GFAP-EFNA3)181Kln/0 (involves: C57BL/6 * FVB)	increased susceptibility to pharmacologically induced seizures	J:154648
\Tg(Gfap-GFAP*R239H)60TMIke/0 (involves: C57BL/6J)	increased susceptibility to pharmacologically induced seizures	J:139349
\Tg(Lgi1*)#Mpan/0 (Not Specified)	increased susceptibility to pharmacologically induced seizures	J:154129
\Tg(Lmnb1)1Yfu/0 (involves: C57BL/6J)	increased susceptibility to pharmacologically induced seizures	J:197168
\Tg(Mov1/Tyr)OVE876BPay/Y (FVB/N-Tg(Mov1/Tyr)OVE876BPay)	audiogenic seizures	J:167614
\Tg(Mov1/Tyr)OVE876BPay/\Tg(Mov1/Tyr)OVE876BPay (FVB/N-Tg(Mov1/Tyr)OVE876BPay)	audiogenic seizures	J:167614
\Tg(PLP1*)4Rsj/0 (involves: CD-1)	environmentally induced seizures	J:24069
\Tg(Plp1-HTT*150Q)4aXjl/0 (Not Specified)	increased susceptibility to pharmacologically induced seizures	J:221608
\Tg(Prnp-lacZ/ATXN10*)#Teas/0 (involves: FVB/N)	increased susceptibility to pharmacologically induced seizures	J:222081
\Tg(Prnp-tTA)F959Sbp/? \Tg(TetO-NfkbiaS32AS36A)1Wcg/? (involves: 129S7/SvEvBrd * DBA * FVB/N)	environmentally induced seizures	J:112973
\Tg(Scn1a*)RH9Aesc/0 (involves: FVB/NJ)	increased susceptibility to pharmacologically induced seizures	J:150454
\Tg(Thy1-AppR609DK612E)4Vln/\Tg(Thy1-AppR609DK612E)4Vln (involves: FVB)	decreased susceptibility to pharmacologically induced seizures	J:32213
	increased susceptibility to pharmacologically induced seizures	J:32213
\Tg(Thy1-AppR609DK612E)6Vln/\Tg(Thy1-AppR609DK612E)6Vln (involves: FVB)	decreased susceptibility to pharmacologically induced seizures	J:32213
	increased susceptibility to pharmacologically induced seizures	J:32213
\Tg(Thy1-MAPT)1Avil/\Tg(Thy1-MAPT)1Avil (involves: C57BL/6 * CBA)	increased susceptibility to pharmacologically induced seizures	J:201700
\Tg(Thy1-SERPINI1G392E)333Icka/0 (involves: C57BL CD-1 * DBA)	increased susceptibility to pharmacologically induced seizures	J:144649
\Tg(Thy1-SERPINI1G392E)333Icka/\Tg(Thy1-SERPINI1G392E)333Icka (involves: C57BL * CD-1 * DBA)	increased susceptibility to pharmacologically induced seizures	J:144649
\Tg(UBC-Adk)1Bois/0 (B6;129P3-Adk^tm1Bois Tg(UBC-Adk)1Bois)	abnormal seizure response to pharmacological agent	J:105483
\Thrb^tm1Df/\Thrb^tm1Df (either: B6.129S1-Thrb^tm1Df or (involves: 129S1/Sv * C57BL/6J))	audiogenic seizures	J:103702
\Tmem151b^nmf389/\Tmem151b⁺ (B6N.B6J-Tmem151b^nmf389/FrkJ)	abnormal seizure response to electrical stimulation	J:362012
\Tmem151b^nmf389/\Tmem151b^nmf389 (B6N.B6J-Tmem151b^nmf389/FrkJ)	abnormal seizure response to electrical stimulation	J:362012
	increased kindling response	J:362012
	maximal tonic hindlimb extension seizures	J:362012
\Tmem151b^nmf389/\Tmem151b^nmf389 (C57BL/6J-Tmem151b^nmf389/J)	abnormal seizure response to electrical stimulation	J:362012
	increased kindling response	J:362012
	maximal tonic hindlimb extension seizures	J:362012
\Tmem151b^{tm1b(KOMP)Wtsi}/\Tmem151b^nmf389 (B6N.Cg-Tmem151b^{tm1b(KOMP)Wtsi}/Tmem151b^nmf389/Frk)	abnormal seizure response to electrical stimulation	J:362012
	increased kindling response	J:362012
\Tmem151b^{tm1b(KOMP)Wtsi}/\Tmem151b^{tm1b(KOMP)Wtsi} (C57BL/6N-Tmem151b^{tm1b(KOMP)Wtsi}/J)	abnormal seizure response to electrical stimulation	J:362012
	increased kindling response	J:362012
\tmgc61/\tmgc61 (Mixed stock)	decreased susceptibility to pharmacologically induced seizures	J:92490
\Tpp1^tm1Plob/\Tpp1^tm1Plob (involves: 129S1/Sv * C57BL/6)	audiogenic seizures	J:94884
\Trim3^tm1Mak/\Trim3^tm1Mak (B6.129P2-Trim3^tm1Mak)	decreased susceptibility to pharmacologically induced seizures	J:161372
\Trpc5^tm1.1Lbi/Y (involves: 129S6/SvEvTac * C57BL/6 * CBA)	decreased susceptibility to pharmacologically induced seizures	J:194590
\Trpc5^tm1.1Lbi/\Trpc5^tm1.1Lbi (involves: 129S6/SvEvTac * C57BL/6 * CBA)	decreased susceptibility to pharmacologically induced seizures	J:194590
\Tsc2^tm1.1Kcess/\Tsc2^tm1.1Kcess \Emx1^tm1(cre)Krj/\Emx1⁺ (involves: 129S/Sv * C57BL/6J)	environmentally induced seizures	J:195049
\Ttll1^tm1Seto/\Ttll1⁺ \Ttll7^tm1Seto/\Ttll7^tm1Seto (involves: 129 * 129S/SvEv * C57BL/6J)	increased susceptibility to pharmacologically induced seizures	J:345300
\Tubg1^tm2.1Ics/\Tubg1⁺ (involves: C57BL/6N)	increased susceptibility to pharmacologically induced seizures	J:275532
\Tyro3^tm1Grl/\Tyro3^tm1Grl (involves: 129S1/Sv * 129X1/SvJ)	abnormal seizure response to inducing agent	J:54681
\Ube3a^tm1Alb/\Ube3a⁺ (involves: 129S7/SvEvBrd * C57BL/6)	audiogenic seizures	J:50811
\Ube3a^tm1Alb/\Ube3a⁺ (involves: 129S7/SvEvBrd)	audiogenic seizures	J:50811
\Ube3a^tm1Alb/\Ube3a^tm1Alb (involves: 129S7/SvEvBrd * C57BL/6)	audiogenic seizures	J:50811
\Ube3a^tm1Alb/\Ube3a^tm1Alb (involves: 129S7/SvEvBrd)	audiogenic seizures	J:50811
\Ube3a^tm1Yelg/\Ube3a⁺ (involves: 129P2/OlaHsd * 129S2/SvPasCrl)	audiogenic seizures	J:222400
\Usf1^tm1Msw/\Usf1^tm1Msw (involves: 129S7/SvEvBrd * C57BL/6)	environmentally induced seizures	J:46788
\Zbtb20^{Tg(PDGFB-APPSwInd)20Lms}/0 (involves: C57BL/6 * DBA/2)	increased susceptibility to pharmacologically induced seizures	J:121330

Contributing Projects: Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support.	last database update 03/25/2025 MGI 6.24